Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiuli Ma

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
European Journal of Medicinal Chemistry|June 9, 2019
Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitorsRuifang Jia, Jian Zhang, Wei Ai, et al.
Human Genomics|January 3, 2023
Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panelJing Ma, Xiuli Ma, Ken Lin, et al.
Veterinary Sciences|April 26, 2025
Phylogenetic Analysis and Pathogenicity of Avian Reoviruses Isolated from Viral Arthritis Cases in China 2010-2024Liping Liu, Xiao Lu, Xiaozhen Guo, et al.
European Journal of Medicinal Chemistry|January 1, 2021
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavityRuifang Jia, Jian Zhang, Chiara Bertagnin, et al.
Journal of Medicinal Chemistry|December 7, 2024
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance ProfilesJiwei Zhang, Ruifang Jia, Huinan Jia, et al.
European Journal of Medicinal Chemistry|March 17, 2023
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like propertiesRuifang Jia, Jiwei Zhang, Fangyuan Shi, et al.
Transboundary and Emerging Diseases|December 3, 2025
Isolation, Genomic Characterization, and Pathogenicity of a Novel Duck Orbivirus Genetically Similar to Corriparta Virus in ChinaLiping Liu, Xiaozhen Guo, Feng Hu, et al.
European Journal of Medicinal Chemistry|February 25, 2020
Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitorsWei Ai, Jian Zhang, Waleed A Zalloum, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Discovery of Novel Boron-Containing <i>N</i>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-ResistantRuifang Jia, Jiwei Zhang, Jian Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 13, 2023
A novel <i>N</i>-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluationJiwei Zhang, Chuanfeng Liu, Ruifang Jia, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|June 9, 2019
Design, synthesis and biological evaluation of "Multi-Site"-binding influenza virus neuraminidase inhibitorsRuifang Jia, Jian Zhang, Wei Ai, et al.
Human Genomics|January 3, 2023
Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panelJing Ma, Xiuli Ma, Ken Lin, et al.
Veterinary Sciences|April 26, 2025
Phylogenetic Analysis and Pathogenicity of Avian Reoviruses Isolated from Viral Arthritis Cases in China 2010-2024Liping Liu, Xiao Lu, Xiaozhen Guo, et al.
European Journal of Medicinal Chemistry|January 1, 2021
Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavityRuifang Jia, Jian Zhang, Chiara Bertagnin, et al.
Journal of Medicinal Chemistry|December 7, 2024
Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance ProfilesJiwei Zhang, Ruifang Jia, Huinan Jia, et al.
European Journal of Medicinal Chemistry|March 17, 2023
Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like propertiesRuifang Jia, Jiwei Zhang, Fangyuan Shi, et al.
Transboundary and Emerging Diseases|December 3, 2025
Isolation, Genomic Characterization, and Pathogenicity of a Novel Duck Orbivirus Genetically Similar to Corriparta Virus in ChinaLiping Liu, Xiaozhen Guo, Feng Hu, et al.
European Journal of Medicinal Chemistry|February 25, 2020
Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitorsWei Ai, Jian Zhang, Waleed A Zalloum, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Discovery of Novel Boron-Containing <i>N</i>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-ResistantRuifang Jia, Jiwei Zhang, Jian Zhang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|November 13, 2023
A novel <i>N</i>-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluationJiwei Zhang, Chuanfeng Liu, Ruifang Jia, et al.
Pageof 10